Personal information

No personal information available

Activities

Collapse all

Works (50 of 88)

Items per page:
Page 1 of 2

On‐Treatment Platelet Reactivity and Ischemic Outcomes in Patients With Diabetes Mellitus: Two‐Year Results From ADAPT‐DES

Journal of the American Heart Association
2023-01-03 | Journal article
DOI: 10.1161/JAHA.122.026482
Contributors: Bahira Shahim; Björn Redfors; Thomas D. Stuckey; Mengdan Liu; Zhipeng Zhou; Bernhard Witzenbichler; Giora Weisz; Michael J. Rinaldi; Franz‐Josef Neumann; D. Christopher Metzger et al.
Source: check_circle
Crossref

Prior Myocardial Infarction and Treatment Effect of Ticagrelor Versus Prasugrel in Patients With Acute Coronary Syndromes ‐ A Post‐hoc Analysis of the ISAR‐REACT 5 Trial

Journal of the American Heart Association
2022-12-20 | Journal article
DOI: 10.1161/JAHA.122.027257
Contributors: Shqipdona Lahu; Maria Scalamogna; Gjin Ndrepepa; Maurizio Menichelli; Christian Valina; Rayyan Hemetsberger; Bernhard Witzenbichler; Isabell Bernlochner; Michael Joner; Erion Xhepa et al.
Source: check_circle
Crossref

Ticagrelor or Prasugrel in Patients With Acute Coronary Syndrome and High Bleeding Risk

Circulation: Cardiovascular Interventions
2022-10 | Journal article
DOI: 10.1161/CIRCINTERVENTIONS.122.012204
Contributors: Shqipdona Lahu; Antonia Presch; Gjin Ndrepepa; Maurizio Menichelli; Christian Valina; Rayyan Hemetsberger; Bernhard Witzenbichler; Isabell Bernlochner; Michael Joner; Erion Xhepa et al.
Source: check_circle
Crossref

Pre-admission antiplatelet therapy and treatment effect of ticagrelor vs. prasugrel in patients with acute coronary syndromes—a subgroup analysis of the ISAR-REACT 5 trial

European Heart Journal - Cardiovascular Pharmacotherapy
2022-09-29 | Journal article
DOI: 10.1093/ehjcvp/pvac007
Contributors: Shqipdona Lahu; Gjin Ndrepepa; Franz-Josef Neumann; Maurizio Menichelli; Isabell Bernlochner; Gert Richardt; Jochen Wöhrle; Bernhard Witzenbichler; Rayyan Hemetsberger; Katharina Mayer et al.
Source: check_circle
Crossref

Assessment of Impact of Patient Recruitment Volume on Risk Profile, Outcomes, and Treatment Effect in a Randomized Trial of Ticagrelor Versus Prasugrel in Acute Coronary Syndromes

Journal of the American Heart Association
2021-11-16 | Journal article
DOI: 10.1161/JAHA.121.021418
Contributors: Gjin Ndrepepa; Franz‐Josef Neumann; Maurizio Menichelli; Isabell Bernlochner; Gert Richardt; Jochen Wöhrle; Bernhard Witzenbichler; Katharina Mayer; Salvatore Cassese; Senta Gewalt et al.
Source: check_circle
Crossref

Does calcium burden impact culprit lesion morphology and clinical results? An ADAPT-DES IVUS substudy

International Journal of Cardiology
2017-12 | Journal article
DOI: 10.1016/j.ijcard.2017.08.028
Contributors: Peiren Shan; Gary S. Mintz; Bernhard Witzenbichler; D. Christopher Metzger; Michael J. Rinaldi; Peter L. Duffy; Giora Weisz; Thomas D. Stuckey; Bruce R. Brodie; Philippe Généreux et al.
Source: check_circle
Crossref

Two-year outcomes after percutaneous coronary intervention of calcified lesions with drug-eluting stents

International Journal of Cardiology
2017-03 | Journal article
DOI: 10.1016/j.ijcard.2016.12.150
Contributors: Philippe Généreux; Björn Redfors; Bernhard Witzenbichler; Marie-Pier Arsenault; Giora Weisz; Thomas D. Stuckey; Michael J. Rinaldi; Franz-Josef Neumann; D. Christopher Metzger; Timothy D. Henry et al.
Source: check_circle
Crossref

Usefulness of the Left Anterior Descending Coronary Artery Wrapping Around the Left Ventricular Apex to Predict Adverse Clinical Outcomes in Patients With Anterior Wall ST-Segment Elevation Myocardial Infarction (from the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction Trial)

The American Journal of Cardiology
2015-12 | Journal article
DOI: 10.1016/j.amjcard.2015.09.004
Contributors: Nobuaki Kobayashi; Akiko Maehara; Sorin J. Brener; Philippe Généreux; Bernhard Witzenbichler; Giulio Guagliumi; Jan Z. Peruga; Roxana Mehran; Gary S. Mintz; Gregg W. Stone
Source: check_circle
Crossref

Postprocedural Anticoagulation for Specific Therapeutic Indications After Revascularization for ST-Segment Elevation Myocardial Infarction (from the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction Trial)

The American Journal of Cardiology
2014-11 | Journal article
DOI: 10.1016/j.amjcard.2014.07.061
Source: check_circle
Crossref

Outcomes in Patients With ST-Segment Elevation Acute Myocardial Infarction Treated With Clopidogrel Versus Prasugrel (from the INFUSE-AMI Trial)

The American Journal of Cardiology
2014-05 | Journal article
DOI: 10.1016/j.amjcard.2014.02.002
Source: check_circle
Crossref

Coronary artery treatment with paclitaxel-coated balloon using a BTHC excipient: clinical results of the international real-world DELUX registry.

2013-12 | Journal article
PMID:

24345357
Contributors: Toelg R; Merkely B; Erglis A; Hoffman S; Bruno H; Kornowski R; Slagboom T; Naber C; Witzenbichler B; Graf K et al.
Source: Self-asserted source
Bernhard Witzenbichler via Europe PubMed Central

Relation Between White Blood Cell Count and Final Infarct Size in Patients With ST-Segment Elevation Acute Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention (from the INFUSE AMI Trial).

2013-12 | Journal article
DOI:

10.1016/j.amjcard.2013.08.010

PMID:

24063843
Contributors: Palmerini T; Brener SJ; Genereux P; Maehara A; Della Riva D; Mariani A; Witzenbichler B; Godlewski J; Parise H; Dambrink JH et al.
Source: Self-asserted source
Bernhard Witzenbichler via Europe PubMed Central

Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention (PARIS): 2 year results from a prospective observational study.

2013-11 | Journal article
DOI:

10.1016/S0140-6736(13)61720-1

PMID:

24004642
Contributors: Mehran R; Baber U; Steg PG; Ariti C; Weisz G; Witzenbichler B; Henry TD; Kini AS; Stuckey T; Cohen DJ et al.
Source: Self-asserted source
Bernhard Witzenbichler via Europe PubMed Central

Relationship Between Intravascular Ultrasound Guidance and Clinical Outcomes After Drug-Eluting Stents: The ADAPT-DES Study.

2013-11 | Journal article
PMID:

24281330
Contributors: Witzenbichler B; Maehara A; Weisz G; Neumann FJ; Rinaldi MJ; Metzger DC; Henry TD; Cox DA; Duffy PL; Brodie BR et al.
Source: Self-asserted source
Bernhard Witzenbichler via Europe PubMed Central

Complementary prognostic utility of myocardial blush grade and ST-segment resolution after primary percutaneous coronary intervention: analysis from the HORIZONS-AMI trial.

2013-10 | Journal article
DOI:

10.1016/j.ahj.2013.07.025

PMID:

24093847
Contributors: Brener SJ; Dizon JM; Mehran R; Guerchicoff A; Lansky AJ; Farkouh M; Brodie B; Guagliumi G; Witzenbichler B; Fahy M et al.
Source: Self-asserted source
Bernhard Witzenbichler via Europe PubMed Central

Coronary reperfusion and clinical outcomes after thrombus aspiration during primary percutaneous coronary intervention: findings from the HORIZONS-AMI trial.

2013-10 | Journal article
DOI:

10.1002/ccd.24705

PMID:

23074151
Contributors: Nilsen DW; Mehran R; Wu RS; Yu J; Nordrehaug JE; Brodie BR; Witzenbichler B; Nikolsky E; Fahy M; Stone GW
Source: Self-asserted source
Bernhard Witzenbichler via Europe PubMed Central

Intralesional abciximab and thrombus aspiration in patients with large anterior myocardial infarction: one-year results from the INFUSE-AMI trial.

2013-10 | Journal article
DOI:

10.1161/CIRCINTERVENTIONS.113.000644

PMID:

24084626
Contributors: Stone GW; Witzenbichler B; Godlewski J; Dambrink JH; Ochala A; Chowdhary S; El-Omar M; Neunteufl T; Metzger DC; Dizon JM et al.
Source: Self-asserted source
Bernhard Witzenbichler via Europe PubMed Central

Impact of bivalirudin and paclitaxel-eluting stents on outcomes in patients undergoing primary percutaneous coronary intervention of the left anterior descending artery.

2013-09 | Journal article
DOI:

10.1016/j.amjcard.2013.05.006

PMID:

23746479
Contributors: Wöhrle J; Brodie B; Witzenbichler B; Dudek D; Kornowski R; Metzger C; Grines C; McAndrew TC; Parise H; Sergie Z et al.
Source: Self-asserted source
Bernhard Witzenbichler via Europe PubMed Central

Impact of hyperglycemia in patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention: the HORIZONS-AMI trial.

2013-09 | Journal article
DOI:

10.1016/j.ijcard.2012.06.054

PMID:

22795245
Contributors: Planer D; Witzenbichler B; Guagliumi G; Peruga JZ; Brodie BR; Xu K; Fahy M; Mehran R; Stone GW
Source: Self-asserted source
Bernhard Witzenbichler via Europe PubMed Central

Outcomes in diabetic patients undergoing primary percutaneous coronary intervention for acute anterior myocardial infarction: Results from the INFUSE-AMI study.

2013-09 | Journal article
PMID:

24030863
Contributors: Sanidas EA; Brener SJ; Maehara A; Généreux P; Witzenbichler B; El-Omar M; Fahy M; Mehran R; Gibson CM; Stone GW
Source: Self-asserted source
Bernhard Witzenbichler via Europe PubMed Central

D-dimer levels predict ischemic and hemorrhagic outcomes after acute myocardial infarction: a HORIZONS-AMI biomarker substudy.

2013-08 | Journal article
DOI:

10.1007/s11239-013-0953-5

PMID:

23925451
Contributors: Kikkert WJ; Claessen BE; Stone GW; Mehran R; Witzenbichler B; Brodie BR; Wöhrle J; Witkowski A; Guagliumi G; Zmudka K et al.
Source: Self-asserted source
Bernhard Witzenbichler via Europe PubMed Central

Plaque shift and distal embolism in patients with acute myocardial infarction: a volumetric intravascular ultrasound analysis from the HORIZONS-AMI trial.

2013-08 | Journal article
DOI:

10.1002/ccd.24644

PMID:

22936619
Contributors: Wu X; Maehara A; He Y; Xu K; Oviedo C; Witzenbichler B; Lansky AJ; Dressler O; Parise H; Stone GW et al.
Source: Self-asserted source
Bernhard Witzenbichler via Europe PubMed Central

Platelet reactivity and clinical outcomes after coronary artery implantation of drug-eluting stents (ADAPT-DES): a prospective multicentre registry study.

2013-08 | Journal article
DOI:

10.1016/S0140-6736(13)61170-8

PMID:

23890998
Contributors: Stone GW; Witzenbichler B; Weisz G; Rinaldi MJ; Neumann FJ; Metzger DC; Henry TD; Cox DA; Duffy PL; Mazzaferri E et al.
Source: Self-asserted source
Bernhard Witzenbichler via Europe PubMed Central

Infarct size and mortality in patients with proximal versus mid left anterior descending artery occlusion: the Intracoronary Abciximab and Aspiration Thrombectomy in Patients With Large Anterior Myocardial Infarction (INFUSE-AMI) trial.

2013-07 | Journal article
DOI:

10.1016/j.ahj.2013.03.029

PMID:

23816023
Contributors: Brener SJ; Witzenbichler B; Maehara A; Dizon J; Fahy M; El-Omar M; Dambrink JH; Genereux P; Mehran R; Oldroyd K et al.
Source: Self-asserted source
Bernhard Witzenbichler via Europe PubMed Central

Relationship between myocardial reperfusion, infarct size, and mortality: the INFUSE-AMI (Intracoronary Abciximab and Aspiration Thrombectomy in Patients With Large Anterior Myocardial Infarction) trial.

2013-07 | Journal article
DOI:

10.1016/j.jcin.2013.03.013

PMID:

23866184
Contributors: Brener SJ; Maehara A; Dizon JM; Fahy M; Witzenbichler B; Parise H; El-Omar M; Dambrink JH; Mehran R; Oldroyd K et al.
Source: Self-asserted source
Bernhard Witzenbichler via Europe PubMed Central

Frequency, mechanisms, and implications of late peri-stent contrast staining: analysis (from the HORIZONS-AMI Trial).

2013-06 | Journal article
DOI:

10.1016/j.amjcard.2013.01.329

PMID:

23497778
Contributors: Yakushiji T; Inaba S; Maehara A; Brener SJ; Witzenbichler B; Guagliumi G; Brodie BR; Kellett MA Jr; Xu K; Mehran R et al.
Source: Self-asserted source
Bernhard Witzenbichler via Europe PubMed Central

Predictors of suboptimal TIMI flow after primary angioplasty for acute myocardial infarction: results from the HORIZONS-AMI trial.

2013-06 | Journal article
DOI:

10.4244/EIJV9I2A37

PMID:

23518872
Contributors: Caixeta A; Lansky AJ; Mehran R; Brener SJ; Claessen B; Généreux P; Palmerini T; Witzenbichler B; Guagliumi G; Brodie BR et al.
Source: Self-asserted source
Bernhard Witzenbichler via Europe PubMed Central

Comparison of outcomes of patients with ST-segment elevation myocardial infarction with versus without previous coronary artery bypass grafting (from the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction [HORIZONS-AMI] trial).

2013-05 | Journal article
DOI:

10.1016/j.amjcard.2013.01.285

PMID:

23465098
Contributors: Nikolsky E; Mehran R; Yu J; Witzenbichler B; Brodie BR; Kornowski R; Brener S; Xu K; Dangas GD; Stone GW
Source: Self-asserted source
Bernhard Witzenbichler via Europe PubMed Central

Outcome of patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention during on- versus off-hours (a Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction [HORIZONS-AMI] trial substudy).

2013-04 | Journal article
DOI:

10.1016/j.amjcard.2012.11.062

PMID:

23340031
Contributors: Cubeddu RJ; Palacios IF; Blankenship JC; Horvath SA; Xu K; Kovacic JC; Dangas GD; Witzenbichler B; Guagliumi G; Kornowski R et al.
Source: Self-asserted source
Bernhard Witzenbichler via Europe PubMed Central

Impact of infarct-related artery patency before primary PCI on outcome in patients with ST-segment elevation myocardial infarction: the HORIZONS-AMI trial.

2013-03 | Journal article
DOI:

10.4244/EIJV8I11A199

PMID:

23538158
Contributors: Rakowski T; Dudek D; Dziewierz A; Yu J; Witzenbichler B; Guagliumi G; Kornowski R; Hartmann F; Lansky AJ; Brener SJ et al.
Source: Self-asserted source
Bernhard Witzenbichler via Europe PubMed Central

Long-term prognosis of patients presenting with ST-segment elevation myocardial infarction with no significant coronary artery disease (from the HORIZONS-AMI trial).

2013-03 | Journal article
DOI:

10.1016/j.amjcard.2012.11.011

PMID:

23261001
Contributors: Larsen AI; Nilsen DW; Yu J; Mehran R; Nikolsky E; Lansky AJ; Caixeta A; Parise H; Fahy M; Cristea E et al.
Source: Self-asserted source
Bernhard Witzenbichler via Europe PubMed Central

Adverse event rates following primary PCI for STEMI at US and non-US hospitals: three-year analysis from the HORIZONS-AMI trial.

2013-02 | Journal article
DOI:

10.4244/EIJV8I10A176

PMID:

23425539
Contributors: Tobbia P; Brodie BR; Witzenbichler B; Metzger C; Guagliumi G; Yu J; Kellett MA; Stuckey T; Fahy M; Mehran R et al.
Source: Self-asserted source
Bernhard Witzenbichler via Europe PubMed Central

Relationship between biomarkers and subsequent bleeding risk in ST-segment elevation myocardial infarction patients treated with paclitaxel-eluting stents: a HORIZONS-AMI substudy.

2013-02 | Journal article
DOI:

10.1007/s11239-012-0837-0

PMID:

23212802
Contributors: Kikkert WJ; Claessen BE; Stone GW; Mehran R; Witzenbichler B; Brodie BR; Wöhrle J; Witkowski A; Guagliumi G; Zmudka K et al.
Source: Self-asserted source
Bernhard Witzenbichler via Europe PubMed Central

Comparison of Three-year outcomes after primary percutaneous coronary intervention in patients with left ventricular ejection fraction <40% versus ≥ 40% (from the HORIZONS-AMI trial).

2013-01 | Journal article
DOI:

10.1016/j.amjcard.2012.08.040

PMID:

23040595
Contributors: Daneault B; Généreux P; Kirtane AJ; Witzenbichler B; Guagliumi G; Paradis JM; Fahy MP; Mehran R; Stone GW
Source: Self-asserted source
Bernhard Witzenbichler via Europe PubMed Central

Dynamic nature of nonculprit coronary artery lesion morphology in STEMI: a serial IVUS analysis from the HORIZONS-AMI trial.

2013-01 | Journal article
DOI:

10.1016/j.jcmg.2012.08.010

PMID:

23328566
Contributors: Zhao Z; Witzenbichler B; Mintz GS; Jaster M; Choi SY; Wu X; He Y; Margolis MP; Dressler O; Cristea E et al.
Source: Self-asserted source
Bernhard Witzenbichler via Europe PubMed Central

Impact of advanced age on the safety and effectiveness of paclitaxel-eluting stent implantation in patients with ST-segment elevation myocardial infarction undergoing primary angioplasty: The HORIZONS-AMI trial.

2013-01 | Journal article
PMID:

23359554
Contributors: Dudek D; Mehran R; Dziewierz A; Witzenbichler B; Brodie BR; Kornowski R; Fahy M; Lansky AJ; Rakowski T; Legutko J et al.
Source: Self-asserted source
Bernhard Witzenbichler via Europe PubMed Central

Relationship between the intensity of heparin anticoagulation and clinical outcomes in patients receiving glycoprotein IIb/IIIa inhibitors during primary percutaneous coronary intervention in acute myocardial infarction.

2013-01 | Journal article
DOI:

10.1002/ccd.24279

PMID:

22511592
Contributors: Rozenman Y; Mehran R; Witzenbichler B; Dangas G; Desaga M; Kochman J; Nilsen DW; Finkelstein A; Mosseri M; Stone GW
Source: Self-asserted source
Bernhard Witzenbichler via Europe PubMed Central

B-type natriuretic peptide and risk of contrast-induced acute kidney injury in acute ST-segment-elevation myocardial infarction: a substudy from the HORIZONS-AMI trial.

2012-12 | Journal article
DOI:

10.1161/CIRCINTERVENTIONS.112.972356

PMID:

23192919
Contributors: Jarai R; Dangas G; Huber K; Xu K; Brodie BR; Witzenbichler B; Metzger DC; Radke PW; Yu J; Claessen BE et al.
Source: Self-asserted source
Bernhard Witzenbichler via Europe PubMed Central

Safety and efficacy of high- versus low-dose aspirin after primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) trial.

2012-12 | Journal article
DOI:

10.1016/j.jcin.2012.07.016

PMID:

23257371
Contributors: Yu J; Mehran R; Dangas GD; Claessen BE; Baber U; Xu K; Parise H; Fahy M; Lansky AJ; Witzenbichler B et al.
Source: Self-asserted source
Bernhard Witzenbichler via Europe PubMed Central

Self-expanding versus balloon-expandable stents in acute myocardial infarction: results from the APPOSITION II study: self-expanding stents in ST-segment elevation myocardial infarction.

2012-12 | Journal article
DOI:

10.1016/j.jcin.2012.08.016

PMID:

23257368
Contributors: van Geuns RJ; Tamburino C; Fajadet J; Vrolix M; Witzenbichler B; Eeckhout E; Spaulding C; Reczuch K; La Manna A; Spaargaren R et al.
Source: Self-asserted source
Bernhard Witzenbichler via Europe PubMed Central

Comparison of abciximab versus eptifibatide during percutaneous coronary intervention in ST-segment elevation myocardial infarction (from the HORIZONS-AMI trial).

2012-10 | Journal article
DOI:

10.1016/j.amjcard.2012.05.026

PMID:

22748356
Contributors: Singh HS; Dangas GD; Guagliumi G; Yu J; Witzenbichler B; Kornowski R; Grines C; Gersh B; Dudek D; Mehran R et al.
Source: Self-asserted source
Bernhard Witzenbichler via Europe PubMed Central

Dual antiplatelet therapy after drug-eluting stent implantation: is it time to slacken the reins?

2012-10 | Journal article
DOI:

10.1016/j.jacc.2012.08.003

PMID:

22999715
Contributors: Witzenbichler B
Source: Self-asserted source
Bernhard Witzenbichler via Europe PubMed Central

Relationship between biomarkers and subsequent clinical and angiographic restenosis after paclitaxel-eluting stents for treatment of STEMI: a HORIZONS-AMI substudy.

2012-08 | Journal article
DOI:

10.1007/s11239-012-0706-x

PMID:

22466810
Contributors: Claessen BE; Stone GW; Mehran R; Witzenbichler B; Brodie BR; Wöhrle J; Witkowski A; Guagliumi G; Zmudka K; Henriques JP et al.
Source: Self-asserted source
Bernhard Witzenbichler via Europe PubMed Central

Clinical outcomes following stent thrombosis occurring in-hospital versus out-of-hospital: results from the HORIZONS-AMI (Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction) trial.

2012-05 | Journal article
DOI:

10.1016/j.jacc.2011.12.042

PMID:

22575312
Contributors: Dangas GD; Claessen BE; Mehran R; Brener S; Brodie BR; Dudek D; Witzenbichler B; Peruga JZ; Guagliumi G; Moses JW et al.
Source: Self-asserted source
Bernhard Witzenbichler via Europe PubMed Central

Intracoronary abciximab and aspiration thrombectomy in patients with large anterior myocardial infarction: the INFUSE-AMI randomized trial.

2012-05 | Journal article
DOI:

10.1001/jama.2012.421

PMID:

22447888
Contributors: Stone GW; Maehara A; Witzenbichler B; Godlewski J; Parise H; Dambrink JH; Ochala A; Carlton TW; Cristea E; Wolff SD et al.
Source: Self-asserted source
Bernhard Witzenbichler via Europe PubMed Central

Long-term follow-up of attenuated plaques in patients with acute myocardial infarction: an intravascular ultrasound substudy of the HORIZONS-AMI trial.

2012-04 | Journal article
DOI:

10.1161/CIRCINTERVENTIONS.111.964684

PMID:

22438429
Contributors: Xu K; Mintz GS; Kubo T; Wu X; Guo N; Yang J; Witzenbichler B; Guagliumi G; Brodie B; Dressler O et al.
Source: Self-asserted source
Bernhard Witzenbichler via Europe PubMed Central

Prognostic impact of a chronic total occlusion in a non-infarct-related artery in patients with ST-segment elevation myocardial infarction: 3-year results from the HORIZONS-AMI trial.

2012-03 | Journal article
DOI:

10.1093/eurheartj/ehr471

PMID:

22240495
Contributors: Claessen BE; Dangas GD; Weisz G; Witzenbichler B; Guagliumi G; Möckel M; Brener SJ; Xu K; Henriques JP; Mehran R et al.
Source: Self-asserted source
Bernhard Witzenbichler via Europe PubMed Central

Usefulness of minimum stent cross sectional area as a predictor of angiographic restenosis after primary percutaneous coronary intervention in acute myocardial infarction (from the HORIZONS-AMI Trial IVUS substudy).

2012-02 | Journal article
DOI:

10.1016/j.amjcard.2011.10.005

PMID:

22118823
Contributors: Choi SY; Maehara A; Cristea E; Witzenbichler B; Guagliumi G; Brodie B; Kellett MA Jr; Dressler O; Lansky AJ; Parise H et al.
Source: Self-asserted source
Bernhard Witzenbichler via Europe PubMed Central

Comparison of direct stenting with conventional stent implantation in acute myocardial infarction.

2011-12 | Journal article
DOI:

10.1016/j.amjcard.2011.07.040

PMID:

21906709
Contributors: Möckel M; Vollert J; Lansky AJ; Witzenbichler B; Guagliumi G; Peruga JZ; Brodie BR; Kornowski R; Dudek D; Farkouh ME et al.
Source: Self-asserted source
Bernhard Witzenbichler via Europe PubMed Central

Radial access in patients with ST-segment elevation myocardial infarction undergoing primary angioplasty in acute myocardial infarction: the HORIZONS-AMI trial.

2011-12 | Journal article
DOI:

10.4244/EIJV7I8A144

PMID:

22157475
Contributors: Généreux P; Mehran R; Palmerini T; Caixeta A; Kirtane AJ; Lansky AJ; Brodie BR; Witzenbichler B; Mockel M; Guagliumi G et al.
Source: Self-asserted source
Bernhard Witzenbichler via Europe PubMed Central
Items per page:
Page 1 of 2
How many people are using ORCID?